NMTC
NMTC
NASDAQ · Health Care

Neuroone Medical Technologie

$1.94
+0.11 (+6.01%)
As of Aug 15, 2:25 AM ET ·
Financial Highlights (FY 2026)
Revenue
15.21M
Net Income
-4,531,213
Gross Margin
67.3%
Profit Margin
-29.8%
Rev Growth
+78.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.3% 67.3% 33.8% 33.8%
Operating Margin -34.9% -31.4% 18.5% 22.7%
Profit Margin -29.8% -28.3% 17.8% 17.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 15.21M 8.51M 9.42M 7.53M
Gross Profit 10.23M 5.73M 3.18M 2.55M
Operating Income -5,312,718 -2,675,683 1.75M 1.71M
Net Income -4,531,213 -2,282,088 1.68M 1.31M
Gross Margin 67.3% 67.3% 33.8% 33.8%
Operating Margin -34.9% -31.4% 18.5% 22.7%
Profit Margin -29.8% -28.3% 17.8% 17.4%
Rev Growth +78.7% +78.7% +23.2% +0.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 19.89M 16.57M
Total Equity 26.14M 26.84M
D/E Ratio 0.76 0.62
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -4,982,905 -2,648,998 2.43M 1.90M
Free Cash Flow 1.05M 840.7K